Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Hepatocellular 8Melanoma 4Uveal Melanoma 3Sarcoma 3Leukemia, Myeloid, Acute 3Glioblastoma 3Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Neoplasms 2Mesothelioma, Malignant 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Skin Neoplasms 1Resectable Hepatocellular Carcinoma 1Recurrence 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leiomyosarcoma 1Ichthyosis, X-Linked 1HER2 Negative Metastatic Breast Cancer 1Colorectal Neoplasms 1Carcinoma 1Advanced Solid Cancers 1Advanced Pancreatic Cancer 1

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × ADI PEG20 × Clear all
NCT00520299 2022-10-25

Study of ADI-PEG 20 in Patients With Advanced Melanoma

Ludwig Institute for Cancer Research

Phase 1/2 Completed
31 enrolled 16 charts
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡